Obalon Enters into a Distribution Agreement for Qatar
December 18, 2019 08:30 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company with the first and only FDA-approved swallowable,...
Obalon To Present at Two Upcoming Institutional Investor Conferences
November 14, 2019 09:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a weight loss solutions company focused on commercializing the Obalon Balloon System, the first and...
Obalon Announces Third Quarter 2019 Financial Results
November 08, 2019 07:15 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon Schedules Third Quarter 2019 Financial Results Conference Call for November 8, 2019 at 9:00 a.m. Eastern Time
October 31, 2019 07:15 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...